Archive · 23 Jul 2026
Cipla Reports Strong Q1 FY27 with ₹785.55 Crore Net Profit
Cipla Limited, a major pharmaceutical company, recently announced its financial results for the first quarter of the fiscal year 2026-27.
The company reported a net profit of ₹785.55 crore, which is higher than the previous quarter but lower than the same quarter last year.
The revenue for this quarter was ₹7,119.28 crore, showing an increase from the last quarter.
The company also saw an increase in total income and expenses.
Additionally, there were some notable items like an exceptional loss in the previous quarter and an impairment of associates.
The earnings per share also improved compared to the last quarter.
Cipla reported a net profit of ₹785.55 crore in Q1 FY27, up from ₹542.51 crore in Q4 FY26.
Revenue increased to ₹7,119.28 crore in Q1 FY27 from ₹6,541.20 crore in Q4 FY26.
Total income for Q1 FY27 was ₹7,330.18 crore, up from ₹6,689.36 crore in Q4 FY26.
Total expenses for Q1 FY27 were ₹6,248.25 crore.
EPS for Q1 FY27 was ₹9.77, higher than ₹6.87 in Q4 FY26.
- Who
- Cipla Limited
- What
- Reported financial results for Q1 FY27
- When
- Quarter ended 30 June 2026
- Where
- Mumbai, India
- Why
- To announce financial performance and operational updates
Positive Financial Performance
Year-over-Year Decline
Revenue Growth
Positive Financial Performance
Cipla's revenue increased to ₹7,119.28 crore in Q1 FY27, up from ₹6,541.20 crore in Q4 FY26.
Year-over-Year Decline
Net profit decreased year-over-year from ₹1,291.61 crore in Q1 FY26 to ₹785.55 crore in Q1 FY27.
- Net Profit (Q1 FY27)
- ₹785.55 crore
- Revenue (Q1 FY27)
- ₹7,119.28 crore
- Net Profit (Q4 FY26)
- ₹542.51 crore
- Revenue (Q4 FY26)
- ₹6,541.20 crore
- Total Income (Q1 FY27)
- ₹7,330.18 crore
- Total Expenses (Q1 FY27)
- ₹6,248.25 crore
- EPS (Q1 FY27)
- ₹9.77
- EPS (Q4 FY26)
- ₹6.87